Carbaglu 200 mg/1
Carglumic Acid · TABLET, FOR SUSPENSION · Recordati Rare Diseases
No Recall History
Plain English
Carbaglu is a tablet, for suspension containing carglumic acid at 200 mg/1, taken oral. Manufactured by Recordati Rare Diseases.
Key Facts
- Brand Name
- Carbaglu
- Generic Name
- Carglumic Acid
- NDC Code (Product)
52276-312- Manufacturer
- Recordati Rare Diseases
- Strength
- 200 mg/1
- Dosage Form
- TABLET, FOR SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- NDA022562
- Drug Class
- Carbamoyl Phosphate Synthetase 1 Activator [EPC]
- Marketing Start
- 03/18/2010
Recall History
No Recall HistoryFrequently Asked Questions
What is Carbaglu used for?
Carbaglu contains Carglumic Acid. It is a tablet, for suspension taken oral. Consult your doctor for specific uses.
Is Carbaglu a controlled substance?
Carbaglu is not classified as a controlled substance by the DEA.
What is the generic name for Carbaglu?
The generic name for Carbaglu is Carglumic Acid. There are 3 other brand versions of Carglumic Acid.
What is the NDC code for Carbaglu 200 mg/1?
The NDC (National Drug Code) for Carbaglu 200 mg/1 is 52276-312, listed by Recordati Rare Diseases.